Zimmer Biomet Holdings, Inc. (ZBH)
92.45
-0.64
(-0.69%)
USD |
NYSE |
Dec 11, 16:00
92.54
+0.09
(+0.10%)
Pre-Market: 06:52
Zimmer Biomet Holdings Research and Development Expense (Quarterly): 115.90M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Stryker Corp. | 398.00M |
| Intuitive Surgical, Inc. | 329.40M |
| Edwards Lifesciences Corp. | 280.70M |
| ResMed, Inc. | 87.32M |
| Nutriband, Inc. | 0.4571M |